» Articles » PMID: 34644404

Gene Replacement Therapy for Spinal Muscular Atrophy Unmasking Occult Hepatitis C in a Pediatric Patient

Overview
Journal Muscle Nerve
Date 2021 Oct 13
PMID 34644404
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Outcomes of early-treated infants with spinal muscular atrophy: A multicenter, retrospective cohort study.

Goedeker N, Rogers A, Fisher M, Arya K, Brandsema J, Farah H Muscle Nerve. 2024; 70(6):1247-1256.

PMID: 39370660 PMC: 11560615. DOI: 10.1002/mus.28267.


Management of Select Adverse Events Following Delandistrogene Moxeparvovec Gene Therapy for Patients With Duchenne Muscular Dystrophy.

Zaidman C, Goedeker N, Aqul A, Butterfield R, Connolly A, Crystal R J Neuromuscul Dis. 2024; 11(3):687-699.

PMID: 38607761 PMC: 11091590. DOI: 10.3233/JND-230185.